Sirolimus and islet transplants

This publication has 22 references indexed in Scilit:

• Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen
  New England Journal of Medicine, 2000
• Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance
  Nature Medicine, 1999
• POSTTRANSPLANT NONFUNCTION OF CANINE ISLETS IN PVG RATS DEFICIENT IN COMPLEMENT COMPONENT C61
  Transplantation, 1998
• EFFICACY OF IMMUNOSUPPRESSIVE DRUGS IN ISLET XENOTRANSPLANTATION
  Transplantation, 1997
• Discordant xenoislets from a large animal donor undergo accelerated graft failure rather than hyperacute rejection: Impact of immunosuppression, islet mass, and transplant site on early outcome
  Surgery, 1997
• THE METABOLIC IMPACT OF RAPAMYCIN (SIROLIMUS) IN CHRONIC CANINE ISLET GRAFT RECIPIENTS1
  Transplantation, 1996
• PROLONGATION OF CANINE PANCREATIC ISLET ALLOGRAFT SURVIVAL WITH COMBINED RAPAMYCIN AND CYCLOSPORINE THERAPY AT LOW DOSES
  Transplantation, 1993
• The Efficacy And Toxicity Of Rapamycin In Murine Islet Transplantation
  Transplantation, 1993
• Rapamycin prevents the onset of insulin-dependent diabetes mellitus (IDDM) in NOD mice
  Clinical and Experimental Immunology, 1992
• SYNERGISTIC INTERACTIONS OF CYCLOSPORINE AND RAPAMYCIN TO INHIBIT IMMUNE PERFORMANCES OF NORMAL HUMAN PERIPHERAL BLOOD LYMPHOCYTES IN VITRO
  Transplantation, 1991